Effect antiplatelet anticoagulant therapy patency femorotibial bypass grafts retrospective study autogenous femorotibial saphenous vein grafts years followed-up mean period months Seven patients grafts hospital grafts groups Sixty grafts patients mg dipyridamole acetylsalicylic acid daily second postoperative day months grafts patients antithrombotic therapy Forty grafts patients warfarin therapy prothrombin time prothrombin-proconvertin method therapeutic range Medication months group high-risk patients groups mean ages incidence risk factors vary groups patency rates groups years ten years dipyridamole acetylsalicylic acid therapy warfarin groups limb salvage rates dipyridamole acetylsalicylic acid therapy warfarin groups results aspirin/dipyridamole group 